Home » Pharmaxis to Acquire Topigen Pharmaceuticals
Pharmaxis to Acquire Topigen Pharmaceuticals
TOPIGEN Pharmaceuticals Inc., a Canadian-based clinical-stage biopharmaceutical company focused on innovative respiratory therapeutics, announced Tuesday
that it has signed an agreement to be acquired by Pharmaxis Ltd., a publicly-traded Australian specialty pharmaceutical company involved in the research,
development and commercialization of therapeutic products for chronic respiratory and immune disorders.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May